Spire Healthcare Group (LON:SPI) Reaches New 1-Year Low – Here’s Why

Spire Healthcare Group plc (LON:SPI)’s stock price hit a new 52-week low during mid-day trading on Monday . The company traded as low as GBX 168.20 ($2.18) and last traded at GBX 173.40 ($2.24), with a volume of 1417725 shares trading hands. The stock had previously closed at GBX 177.20 ($2.29).

Wall Street Analyst Weigh In

Separately, Deutsche Bank Aktiengesellschaft lowered their target price on Spire Healthcare Group from GBX 320 ($4.14) to GBX 300 ($3.88) and set a “buy” rating on the stock in a research note on Thursday, March 6th.

Spire Healthcare Group Trading Up 2.1 %

The company has a debt-to-equity ratio of 62.25, a current ratio of 0.70 and a quick ratio of 0.74. The firm has a fifty day simple moving average of GBX 225.22 and a two-hundred day simple moving average of GBX 228.60. The firm has a market capitalization of £707.12 million, a P/E ratio of 25.06, a price-to-earnings-growth ratio of 1.06 and a beta of 0.96.

Spire Healthcare Group (LON:SPI) last posted its quarterly earnings results on Thursday, March 6th. The company reported GBX 8.80 ($0.11) earnings per share for the quarter. Spire Healthcare Group had a return on equity of 3.82% and a net margin of 1.96%. On average, equities research analysts anticipate that Spire Healthcare Group plc will post 15.6634747 earnings per share for the current fiscal year.

About Spire Healthcare Group

Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics. It offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments.